EHC
Encompass Health Corp
$110.25
-0.47 (-0.42%)
At close · Jul 8
Market Cap
$11.01B
Shares
99,199,080
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-01 | 2026-05-29 | |
| 8-K | 2026-05-15 | 2026-05-14 | |
| 8-K | 2026-05-11 | 2026-05-07 | |
| 10-Q | 2026-05-01 | 2026-03-31 | |
| 8-K | 2026-04-30 | — | |
| DEF 14A | 2026-04-07 | 2026-05-07 | |
| Investor Event Transcript | 2026-03-31 | — | |
| 8-K | 2026-03-10 | 2026-03-09 | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K/A | 2026-02-20 | 2026-02-19 | |
| 8-K | 2026-02-05 | — | |
| 8-K | 2026-02-02 | 2026-01-30 | |
| 8-K | 2025-12-01 | — | |
| 10-Q | 2025-10-31 | 2025-09-30 | |
| 8-K | 2025-10-29 | — | |
| 8-K | 2025-09-18 | 2025-09-17 | |
| 8-K | 2025-09-12 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-08-04 | — | |
| 8-K | 2025-06-25 | — | |
| 8-K | 2025-06-03 | — | |
| 8-K | 2025-05-02 | 2025-05-01 | |
| 10-Q | 2025-05-01 | 2025-03-31 | |
| 8-K | 2025-04-24 | — | |
| DEF 14A | 2025-04-01 | 2025-05-01 | |
| 10-K | 2025-02-28 | 2024-12-31 | |
| 8-K | 2025-02-21 | 2025-02-19 | |
| 8-K | 2025-02-06 | — | |
| 10-Q | 2024-11-01 | 2024-09-30 | |
| 8-K | 2024-10-28 | — | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-08-05 | — | |
| 8-K | 2024-06-21 | — | |
| 8-K | 2024-05-29 | — | |
| 8-K | 2024-05-06 | 2024-05-02 | |
| 10-Q | 2024-05-02 | 2024-03-31 | |
| 8-K | 2024-04-24 | — | |
| DEF 14A | 2024-04-02 | 2024-05-02 | |
| 8-K | 2024-03-11 | — | |
| 8-K | 2024-03-04 | 2024-02-27 | |
| 10-K | 2024-02-28 | 2023-12-31 | |
| 8-K | 2024-02-27 | — | |
| 8-K | 2024-02-07 | — | |
| 8-K | 2023-11-27 | 2023-11-21 | |
| 10-Q | 2023-11-01 | 2023-09-30 | |
| 8-K | 2023-10-26 | — | |
| 8-K | 2023-09-27 | — | |
| 10-Q | 2023-08-04 | 2023-06-30 | |
| 8-K | 2023-08-01 | — | |
| 8-K | 2023-07-25 | 2023-07-20 |
Showing 1–50 of 128 filings
Key facts
CIK
785161
CUSIP
29261A100
13F (30d)
17 filings
16 filers
Visit website
Investor relations